Yes, Alzheimer’s disease causes dementia. It is the single most common cause, responsible for 60% to 80% of all dementia cases. But the relationship between the two terms trips people up because they’re often used interchangeably, even though they describe different things.
Dementia is not a disease. It’s an umbrella term for a decline in memory, thinking, and reasoning severe enough to interfere with daily life. Alzheimer’s is a specific brain disease that happens to be the most frequent reason someone develops dementia. Think of it like chest pain and a heart attack: chest pain is the symptom, and a heart attack is one of several possible causes.
How Alzheimer’s Damages the Brain
Alzheimer’s disease involves two abnormal proteins that accumulate in the brain: amyloid plaques and tau tangles. These proteins work together to damage and eventually destroy the connections between brain cells, called synapses, that are essential for memory and cognition. The damage isn’t caused only by the visible clumps of protein that build up over time. Soluble, free-floating forms of both proteins also push healthy neurons into a diseased state well before plaques and tangles become widespread.
The process starts with amyloid, which triggers tau to shift from its normal, helpful role into a toxic one. Tau then amplifies amyloid’s damage through a feedback loop, accelerating the destruction. As synapses fail and neurons die, the cognitive symptoms we recognize as dementia gradually appear. This process begins years, sometimes over a decade, before a person notices any memory problems.
The Five Stages of Alzheimer’s Dementia
Alzheimer’s develops slowly and worsens over several years, eventually affecting memory, language, judgment, personality, and movement. Clinicians generally recognize five stages.
In the preclinical stage, changes are happening in the brain, but there are no noticeable symptoms. This stage is typically only detected in research settings through brain scans or spinal fluid tests. It can last for years.
The next stage, mild cognitive impairment, brings subtle but real changes. You might forget conversations or recent events more often, struggle to estimate how long a task will take, or find it harder to plan the steps needed to complete something. These changes are noticeable but not yet severe enough to disrupt work or relationships.
In mild dementia, the impact becomes harder to compensate for. Wandering and getting lost in familiar places, repeating questions, and difficulty managing finances or complex tasks are common. Moderate dementia brings more significant changes: trouble recognizing friends and family, impulsive behavior, and increasing need for help with daily activities like dressing and bathing. In severe dementia, a person loses the ability to communicate, may be unable to sit or hold up their head, and eventually loses control of swallowing, bladder, and bowel functions.
Other Causes of Dementia
Because Alzheimer’s accounts for the majority of dementia cases, people often assume the two are the same thing. But several other diseases cause dementia, each with distinct brain changes and symptom patterns.
- Vascular dementia results from disrupted blood flow to the brain, often from blood clots or small strokes. It typically appears after age 65 and can cause poor judgment, difficulty following instructions, and hallucinations.
- Lewy body dementia involves abnormal deposits of a protein called alpha-synuclein. It’s notable for visual hallucinations, muscle rigidity, sleep disturbances, and fluctuating attention. It’s usually diagnosed at age 50 or older.
- Frontotemporal dementia affects the front and side regions of the brain and tends to strike younger, often between ages 45 and 64. Personality changes, impulsive behavior, and language difficulties are more prominent than memory loss in the early stages.
Symptoms across these types overlap, and some people have more than one form of dementia at the same time, which makes accurate diagnosis challenging.
How Alzheimer’s Is Diagnosed
Confirming that Alzheimer’s is the specific cause of someone’s dementia now relies on detecting those two hallmark proteins. PET brain scans can visualize amyloid plaques and tau tangles directly. Spinal fluid tests measure the concentration of these proteins along with related markers. A combination of these approaches gives the most precise diagnosis and helps distinguish Alzheimer’s from other forms of dementia.
This matters more now than it used to because newer treatments are designed specifically for Alzheimer’s and require confirmed amyloid buildup before they can be prescribed.
Genetics and Risk
Alzheimer’s rarely has a single genetic cause. In most cases, multiple genes interact with lifestyle and environmental factors. Researchers have now identified at least 80 genetic regions associated with the disease, up from just 10 in 2010.
The most well-known genetic factor is a gene called APOE, which helps transport cholesterol in the bloodstream. It comes in several forms. The ε4 version increases Alzheimer’s risk and is linked to earlier onset. About 15% to 25% of people carry one copy, and 2% to 5% carry two copies, which raises risk further. Carrying it, however, doesn’t guarantee you’ll develop the disease. Another version, ε2, appears to offer some protection and is found in roughly 5% to 10% of people.
Three rare gene variants are known to directly cause Alzheimer’s rather than simply raise risk. These involve genes on chromosomes 21, 14, and 1, and they tend to cause early-onset disease, sometimes appearing in a person’s 30s or 40s.
Treatment Options
Two newer treatments, approved by the FDA in 2023 and 2024 respectively, represent a significant shift. Unlike older medications that only managed symptoms, these are antibody therapies that target and reduce amyloid plaques in the brain. They’ve shown the ability to slow cognitive decline in people with early-stage Alzheimer’s, including those with mild cognitive impairment or mild dementia. Eligibility requires confirmed amyloid buildup through a brain scan or spinal fluid test, and the treatments do carry a risk of brain swelling or small hemorrhages that need monitoring.
These therapies don’t reverse the disease or work for later stages, but they mark the first time treatments have addressed the underlying biology rather than just the symptoms.
Life Expectancy After Diagnosis
A dementia diagnosis substantially shortens life expectancy, but most people live for years afterward. In a large study of nearly 60,000 people, median survival after diagnosis ranged from about 3 to 4.4 years depending on racial and ethnic background, with younger age at diagnosis associated with longer survival. The range is wide: some people live less than a year after diagnosis, while others live eight years or more. The quarter of patients who survived longest in the study lived six to nearly nine years past their diagnosis, depending on the population.
Age at diagnosis is the strongest predictor. Someone diagnosed in their 60s can expect significantly more years than someone diagnosed in their 80s, though the disease’s progression varies considerably from person to person.